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played greater numbers of colonies formed over those grown in 21%
oxygen (69% vs. 53%). Osteogenic and adipogenic differentiation of SF-
MSCs under 3% oxygen was reduced over cells differentiated in 21%
oxygen. Chondrogenic differentiation under low oxygen tension of 3%
oxygen resulted in elevated levels of GAG/DNA over cells differentiated
in ambient oxygen (mean values of 3.7 mg/mg vs. 1.9 mg/mg).
Conclusions: These studies demonstrate that human SF-MSC pop-
ulations can be expanded under serum-free conditions without loss of
lineage diversity, and that this proliferation can be increased by serially
propagating the cells under 3% oxygen tension to enhance chondro-
genic potential. The propensity of these cells for chondrogenic differ-
entiation increased when the oxygen tension was lowered from 21% to
3% oxygen, in contrast to the osteogenic and adipogenic lineages. Such
low oxygen conditions may better reﬂect the endogenous oxygen levels
in avascular cartilage. Thus, these ﬁndings will contribute to the opti-
mization of bioprocesses aimed at scaling-up and differentiating SF-
MSCs for use in regenerative therapies for articular cartilage.
Figure 1. Representative photomicrographs of a CFU-F assay of cells grown
under 21% (A) and 3% (B) oxygen, to determine their colony forming
ability.
Figure 2. Chondrogenic pellets differentiated under 21% (A,B) and 3% (C,D)
oxygen. Scale bars represent 100 mm.
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Purpose: Cartilage damage is a major problem in osteoarthritis.
Application of bone marrow-derived mesenchymal stem cells (BMSCs)
to heal damaged cartilage is promising due to their capacity to differ-
entiate into chondrocytes. However, clinical results from BMSC-based
therapies are suboptimal because chondrogenic differentiation is vari-
able, and the functional properties of repair tissue differ from native
cartilage. To tackle this problem, we need to better understand the
molecular events during chondrogenic differentiation of BMSCs.Previously, we showed that the SMAD2/3 pathway is crucial for chon-
drogenic differentiation of BMSCs. Transforming Growth Factor-b
(TGFb) is well known to activate this pathway by initiating phosphor-
ylation of SMAD2/3 proteins (pSMAD2/3). Besides TGFb, both Activin A
and Nodal are known to induce pSMAD2/3. Therefore, we investigated
whether Activin A and/or Nodal, like TGFb, can initiate chondrogenesis
in BMSCs.
Methods: Human fetal BMSCs (purchased from ScienCell) were pellet-
cultured in serum-free chondrogenic medium without ligands or with
either 10 ng/mL TGFb1; 10 or 100 ng/mL Activin A; 10 or 100 ng/mL
Nodal for 1 or 7 days. At day 1, proteins were isolated from stimulated
and unstimulated pellets for western blot analysis of pSMAD2/3. To
observe whether cartilage matrix was formed after 7 days, BMSC pellets
were harvested for histological evaluation of proteoglycan deposition
and mRNA expression analysis of aggrecan, collagen type II and
pSMAD2/3-responsive gene plasminogen activator inhibitor-1 (PAI1).
Relative mRNA levels were measured using Q-RT-PCR and corrected for
ribosomal protein S27a expression.
Results: Activin A, TGFb1, and Nodal dose-dependently induced
SMAD2/3 phosphorylation compared to unstimulated BMSC pellets.
pSMAD2/3 levels were highest upon TGFb1 stimulation and lowest
upon Nodal. This was also reﬂected by PAI1 gene expression. However,
despite all three ligands were proven to be bioactive, only TGFb1 ini-
tiated chondrogenic differentiation of fetal BMSC pellets, as shown by
increased ACAN and COL2 expression. Moreover, chondrogenesis was
conﬁrmed in TGFb1-stimulated pellets by positive proteoglycan stain-
ing, whereas pellets stimulated with Activin A or Nodal were devoid of
cartilage-like tissue.
Conclusions: Previously, SMAD2/3 phosphorylation was found crucial
for initiating chondrogenesis in BMSCs. In the present study we dem-
onstrate that TGFb initiated chondrogenic differentiation of BMSCs,
whereas Activin A and Nodal did not. Our data suggest that amongst the
pSMAD2/3-inducing ligands (Activin A, TGFb, or Nodal), only TGFb
initiates chondrogenic differentiation of BMSCs. To improve cartilage
formation by BMSCs, all molecular events induced by TGFb in mesen-
chymal stem cells needs to be further explored.
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CHONDROGENIC PROGENITOR CELLS ARE KEY PLAYERS IN THE
REGENERATION OF CARTILAGE TISSUE
N. Miosge. Univ. Goettingen, Goettingen, Germany
Purpose: The regeneration of diseased hyaline cartilage continues to be
a great challenge, mainly because degeneration overtaxes the tissue's
self-renewal capacity.
Methods: Up to date, more than 600 samples of adult osteoarthritic
cartilage, without signs of rheumatoid involvement, were obtained
from the knee joints of patients (ages: 65 - 75 years) suffering from late-
stage osteoarthritis (OA) after total knee replacement. Recently, we also
includedmeniscus specimens from late OA (n¼ 150), as well as samples
from rheumatoid arthritis (n ¼ 40) in our investigation of progenitor
cells in situ. Histology, immunohistochemistry and staging was carried
out as described. Standard explant cultures were performed. A tran-
scriptome analyses and proteome analysis further characterized the
progenitor cell populations. We performed dilution cloning and lenti-
viral transfection of hTERTof the cells. Quantitative real-time RT-PCR, as
well as Western blotting was applied after overexpression and RNA
silencing experiments for various chondrogenic mediators, for example,
sox9, smad2 or HMGB2. Cell stimulation experiments involved TGFß3,
PDGF or BMP6.
Results: Recently, we demonstrated that repair tissue from human
articular cartilage during the late stages of osteoarthritis harbors a
unique progenitor cell population, termed chondrogenic progenitor
cells (CPCs). These exhibit stem cell characteristics such as clonoge-
nicity, multipotency, and migratory activity. The isolated CPCs, which
exhibit a high chondrogenic potential, were shown to populate diseased
tissue ex vivo. Moreover, down-regulation of the osteogenic tran-
scription factor Runx2 enhanced the expression of the chondrogenic
transcription factor Sox9. This, in turn, increased the matrix synthesis
potential of the CPCs without altering their migratory capacity (Koelling
et al., 2009, Cell Stem Cell). Furthermore, we analyzed sex-speciﬁc
differences in the regenerative potential of CPCs and the involvement of
sex hormones as well as of primary cilia. Migration of CPCs is inﬂuenced
via PDFG receptors. Here, we describe similar progenitor cell pop-
ulations in cartilage tissue of patients with rheumatoid arthritis, as well
